Navitas Life Sciences, a provider of Clinical, Pharmacovigilance, and Regulatory solutions, today announced that it has been named a ‘Major Contender’ in the Everest Group’s Clinical Development Platforms Products PEAK Matrix® Assessment 2022.
Navitas Life Sciences, a provider of Pharmacovigilance, Regulatory, and Clinical solutions, today announced that it has been named as a ‘Major Contender’ in the Everest Group’s Life Sciences Operations PEAK Matrix® Assessment 2022.
10 January, 2022 Navitas Data Sciences, the global Functional Service Provider (FSP) division of Navitas Life Sciences, are delighted that Shrishaila Patil our Vice President of Statistical Programming,
Navitas Life Sciences, a technology-backed global Clinical Research Organization (CRO) and UL, the global safety science leader,
Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and provider of Pharmacovigilance, Regulatory, and Clinical solutions
Navitas Life Sciences, a TAKE Solutions company, announces that it has achieved its 200th customer win for its innovative Regulatory Technology,
Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and provider of Pharmacovigilance, Regulatory, and Clinical solutions and services today announced
ThoughtSphere, a fast growing, cloud-based clinical data hub and analytics SaaS company, today announced that Navitas Life Sciences, a full service CRO....
Navitas Life Sciences, a TAKE Solutions Enterprise today announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc...
Navitas Life Sciences, a TAKE Solutions Enterprise today announced that it will be acquiring Life Sciences services player, DataCeutics in North America.